Clinical Trial â Oral Immunotherapy in Severe Milk, Peanut and Egg Allergy in Adults â Allergy
The aim is to analyse the results of per oral immunotherapy treatment in severe milk, peanut or egg allergy in adults. This is the second part of the oral immunotherapy study in adults at Skin and Allergy Hospital. The diagnosis of food allergy is verified with positive history, skin prick tests, egg and milk allergen specific IgE (immunoglobulin E) antibodies. In addition, food allergy is verified with an open label (milk allergy) or blind (peanut and egg allergy) allergen specific challenge test. OIT (oral immunotherapy) is performed according to a detailed plan. Lung function parameters are followed before OIT and and a year after OIT.
| Study Type  : | Interventional  (Clinical Trial) |
| Estimated Enrollment  : | 100 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Prospective open label study on oral immunotherapy with either milk, or peanut or egg white food products. |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | The Effect of Per Oral Immunotherapy Treatment in Severe IgE Mediated Milk, Peanut and Egg Allergy in Adults |
| Actual Study Start Date  : | August 3, 2017 |
| Estimated Primary Completion Date  : | December 31, 2022 |
| Estimated Study Completion Date  : | December 31, 2022 |
Contacts
| Contact: Paula Kauppi, MD, PhD | +358504286802 | paula.kauppi@hus.fi |
Locations
| Finland | |
| Helsinki University Central Hospital | Recruiting |
| Helsinki, Finland, 00029 | |
| Contact: Paula M Kauppi      paula.kauppi@hus.fi | |
| Contact: Mika J Mäkelä      mika.makela@hus.fi | |
| ClinicalTrials.gov Identifier: | NCT03361072 |
* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.